Valuation (9%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -7.65 | 32.50 |
PEG Ratio (TTM) | -0.08 | 5.87 |
P/S Ratio (TTM) | 18.85 | 5.17 |
P/B Ratio (TTM) | 5.88 | 9.42 |
P/FCF Ratio (TTM) | -7.38 | 24.17 |
Price to 5YR AVG Earnings Ratio | N/A | 33.57 |
Price to 5YR AVG FCF Ratio | N/A | 75.53 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -41.25% | 5.42% |
ROE (TTM) | -71.39% | 21.15% |
Net Profit Margin (TTM) | -245.92% | -28.14% |
ROIC 5YR AVG | N/A | 91.95% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -1.43% | -83.95% | N/A |
Revenue | 44.55% | 41.21% | N/A |
Net Income | -7.37% | -73.98% | N/A |
Cash Flow | -15.04% | -72.06% | N/A |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.46 | 1.99 |
Quick Ratio (TTM) | 3.25 | 1.45 |
D/E Ratio (TTM) | N/A | 1.29 |
Interest Coverage (TTM) | N/A | 16.89 |
Piotroski F-Score | 2 | 6 |
Altman Z-Score | 1.03 | 4.36 |
LTL to 5YR AVG FCF | N/A | 6.35 |
Shares Outstanding Growth 5YR AVG | N/A | 11.16% |